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Background: Asthma remains an important cause of morbidity and mortality, especially in
developing countries but the prevalence in Nigeria is not well described.
Methods: Using the European Community Respiratory Health Survey (ECRHS) standard
screening questionnaire and asthma criteria, we recruited a representative sample of adults
resident in a suburban community in Nigeria through a stratified three-stage cluster sampling
technique.
Results: Out of a total of 3590 individuals contacted, 2310 responded and provided completed
data (62.8% female). The prevalence of respiratory symptoms ranged from 0.4% (95% CI: 0.1
e0.6) to 9.1% (95% CI: 7.6e10.6). Apart from nasal allergies, the most frequently reported
symptoms were ‘woken up by an attack of breathlessness at any time in the last 12 months’
(2.4%, 95% CI: 1.8e3.0) and ‘woken up by an attack of cough at any time in the last 12 months’
(2.9%, 95% CI: 2.0e3.7). The combined proportion of respondents reporting previous asthma
attack or currently taking asthma medication within the preceding 12 months (diagnosed
asthma) was 1.5%, 95% CI: 1.0e2.0. The proportion with ‘probable asthma’ based on ECRHS
criteria of any three symptoms of asthma (woken up by an attack of breathlessness or previous
asthma attack or currently taking asthma medication within the preceding 12 months) was
3.1%, 95% CI: 2.0e4.3 for men and 3.3%, 95% CI: 2.4e4.2 for women.
Conclusion: The prevalence of asthma in this suburban Nigerian population is low. Determi-
nants of adult asthma distribution in low-income setting need further clarification.
ª 2014 Published by Elsevier Ltd.com (D.O. Obaseki), francisolubanjiawoniyi@yahoo.com (F.O. Awoniyi), yemijide@yahoo.com (O.F.
(G.E. Erhabor).
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1582 D.O. Obaseki et al.IntroductionAsthma is recognized globally as a common cause of
morbidity and mortality [1]. Current estimates suggest that
the prevalence of asthma in children and young adolescents
is substantial and stable in high-income countries but
increasing in developing countries, which hitherto, had low
prevalence [2e4]. However, in sub-Saharan Africa, the
prevalence among adults is less studied or understood. Some
prevalence studies on asthma have been conducted in Africa,
but the reported prevalence varies widely. This may partly be
due to the changing dynamics of asthma and its determinants
and/or the use of disparate definitions for asthma. Some
studies define asthma based on self-reported wheeze [5],
others on combinations of asthma symptoms or doctor diag-
nosis [6] and a few others have applied further tests like
spirometry, peak expiratory flow or skin allergy tests [7].
But asthma remains a clinical diagnosis with or without
further investigative confirmatory tests and its prevalence
may be influenced by various factors including environ-
ment, nature of settlements, type of migration, urbaniza-
tion, diet, genetics and other factors related to socio-
economic changes [8].
The burden of asthma in small suburban towns in Nigeria
is not known. Most Nigerians live in small towns; migrating
from rural settlements to live in suburban communities
near big cities like Lagos which is emerging as one of the
densest urban cities worldwide [9]. With increasing eco-
nomic development and the comparative low costs of
settling in these small towns, there’s been a remarkable
increase in small town settlements in Nigeria, many of
which lack basic services or access to quality health care. It
is unclear to what extent these socio-demographic changes
affect the pattern of diseases including asthma [9,10].
Understanding the pattern of asthma in transitional soci-
eties may provide new insight to the drivers of the global
asthma epidemic [11]. Ile-Ife, the site of this study, is a
small university town inhabited by a mix of non-indigenous
university staff and local indigenes. Using the European
Community Respiratory Health Survey (ECRHS) standard
screening questionnaire and asthma criteria [12], we eval-
uated the prevalence of asthma in Ile-Ife, Nigeria and
compared our findings with reports from other centres
worldwide.
Methods
The study was conducted using the protocol developed by
the ECRHS previously described in detail [13].
Population and sampling
The study took place in Ile-Ife, an ancient suburban town in
southwest Nigeria between May 2011 and December 2011.
Though Ile-Ife is host to the Obafemi Awolowo University
with a large student population and ‘middle class’ aca-
demic staff, the town has low vehicular traffic, no major
industries and the indigenes are predominantly agrarian
and petty traders. The study was conducted among the
residents of Ile-Ife town, excluding the university campus.
Ife, as it is commonly called, has two local governmentdistricts (Ife East and Ife Central), and is home to about
250,000 individuals according to the 2006 Nigerian national
census [14].
We did a stratified three-stage sampling of the town.
The first stage was the census tract, also known as
Enumeration Area (EA) and the second and third stages
were households and individuals. With an estimated popu-
lation of 85 individuals per EA, 63% of them being 15 years
and above [14], we randomly selected 64 EAs from a pool of
1658 EAs to attain an initial estimated sample of at least
3456 age eligible individuals. The sample was selected
proportionately from each of the two strata; Ife Central
and Ife East. All households and individuals in the selected
households were included in the sample.
Questionnaire data
All willing participants completed the ECRHS screening
questionnaire, which obtained information about respira-
tory symptoms, asthma diagnosis and treatment, nasal al-
lergies and basic socio-demographic data. The
questionnaire was administered face-to face in the local
language, Yoruba, by trained and certified interviewers in
the respondents’ homes in order to minimize on missing
data. Standard methods for translation including forward
and backward translation, reconciliation and piloting are
part of the ECRHS standardized methods.
Data analysis
All analyses were performed using Stata 11.2 (Stata Corp.,
College Station, TX, USA) [15]. Data describing population
demographics include all responders with complete data.
The proportions of responders with affirmative responses to
each of the questions were analyzed after subdividing the
total sample according to age categories; 15e19 years,
20e44 years, and 45 years and above. Consistent with the
ECRHS protocol, asthma was considered ‘probable’, if a
respondent provided affirmative responses to any of the
following questions: “Have you been woken up by an attack
of breathlessness at any time in the last 12 months”, “Have
you had an attack of asthma in the last 12 months” or “Are
you currently taking any medicines (including inhalers,
aerosols or tablets) for asthma?” [12] A respondent who
responded affirmatively to question 5: “Have you had an
attack of asthma in the last 12 months” or question 6: “Are
you currently taking any medicines (including inhalers,
aerosols or tablets) for asthma” was regarded as ‘diagnosed
asthma’ The analysis was done taking into account the
sampling design using the “svy” set of commands in the
Stata statistical program. The sample weights were derived
for the probability of selection in each of the stages of the
sampling process according to the population strata (Ife East
and Ife Central) and these weights were used to generate
the population prevalence estimates. The ethics committee
of Obafemi Awolowo University hospital approved the study.
Results
Out of a total of 3590 individuals sampled, 905 were un-
reachable after two contact attempts mainly due to work
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had moved out and one had died. Among those reached, 19
actively refused and 203 provided incomplete data. Over-
all, 2310 (amongst which 62.8% were female) provided full
data (Fig. 1). The crude response rate was 64.3% but the
adjusted rate was 67.2% (2310/3437) after accounting for
those who had moved out or died before the survey. The
age distribution of respondents was 12.5% for 15e19 year
olds, 53.0% for 20e44 year olds and 34.5% for those aged 45
years and above (Table 1).
The prevalence of respiratory symptoms ranged from
0.4% (95% CI: 0.1e0.6) to 9$1% (95% CI: 7.6e10.6) in the
overall group. A similar range of prevalence of respiratory
symptoms was also observed in all the age groups. Apart
from nasal allergies (9.1%), the most frequently reported
symptoms were ‘...woken up by an attack of breathlessness
at any time in the last 12 months’ (2.4%, 95% CI: 1.8e3.0)
and ‘....woken up by an attack of cough at any time in the
last 12 months’ (2.9%, 95% CI: 2.0e3.7). The combined
proportion of respondents reporting previous asthma attack
or currently taking asthma medication within the preceding
12 months (diagnosed asthma) was 1.5%, 95% CI: 1.0e2.0,
of the total (Table 2). Table 3 shows the prevalence of
symptoms in the entire population according to sex. Though
males reported more symptoms than females, theFigure 1 Schematic representadifference was not significant (p > 0.05), except in re-
ported wheeze.
Table 4 shows the estimated proportion of respondents
with ‘probable asthma’ and the pattern of their response to
specific questionnaire items. The proportion with ‘probable
asthma’ based on ECRHS criteria of any three symptoms of
asthma (woken up by an attack of breathlessness or pre-
vious asthma attack or currently taking asthma medication
within the preceding 12 months) was 3.2%, 95% CI: 2.6e3.9
for the overall group; for men: 3.1%, 95% CI: 2.0e4.3 and
for women: 3.3%, 95% CI: 2.4e4.2. However in a low
resourced setting with poor access to formal medical care
or physician-based care, the above definition may not be
adequately sensitive for asthma. Using an alternate criteria
that includes any of the above symptoms and an added
question - ‘have you had whistling/wheezing at any time in
the last 12 months’, we found prevalence of 3.7% (95% CI:
3.0e4.5), men: 4.3% (95% CI: 2.9e5.7), women: 3.4% (95%
CI: 2.5e4.3) (Data not shown). Overall, 74.4% (95% CI:
63.9e84.9) of respondents who met ECRHS-defined criteria
for ‘probable asthma’, reported ‘woken up by shortness of
breath in the preceding 12 months’ Table 4 also shows that
respondents with probable asthma aged 15e19 years, were
more likely to be men than women: 26.2%, 95% CI: 8.4e44$1
vs 4$8%, 95% CI: 1.7e11.4, p < 0.05 whereas in those agedtion of the sampling strategy.
Table 1 Demographic characteristics of participants according to age group.
Age group
(years)
Initial sample Responders Crude
response
rate
All Men Women All Men Women %
N (%) Mean
age
(SD)
% Mean
age
(SD)
% Mean
age
(SD)
N (%) Mean
age
(SD)
% Mean
age
(SD)
% Mean
age
(SD)
15e19 524
(14.6)
16.9
(1.5)
15.3 16.9
(1.5)
13.9 16.9
(1.5)
289
(12.5)
17.2
(1.7)
14.5 17.1
(2.1)
11.4 17.3
(1.4)
55.2
20e44 2043
(56.9)
30.2
(6.9)
57.0 30.5
(7.0)
56.8 30.0
(6.8)
1223
(53.0)
30.5
(6.9)
51.9 29.8
(7.2)
53.6 30.9
(6.7)
59.9
45 & Above 1023
(28.5)
58.7
(11.5)
27.7 58.9
(11.4)
29.2 58.6
(11.6)
798
(34.5)
60.6
(11.7)
33$6 61.1
(11.9)
35.0 60.3
(11.6)
78.0
Total 3590 1737 1853 2310 859 1451 64.3
The N (%) and % columns represent the proportions of the total and sex-stratified groups respectively in the various age categories.
The mean age (SD) represent the mean age (SD) for the age groups.
The crude response rate is not inclusive of those who had died or moved out of residence in the study area (153). Overall, the adjusted
response rate is 67$2% (2310/3437).
1584 D.O. Obaseki et al.20e44 years, female respondents were more likely to have
‘probable asthma’ than their male counterparts: 57.1%,
95% CI: 41.9e72$4 vs 41.6%, 95% CI: 23.5e59.7, p < 0.05. A
similar pattern was observed in those aged 45 years and
above.
Table 5 is a comparison of the prevalence of asthma
symptoms in the 20e44 years age group with ECRHS phase 1
results from some centres worldwide, according to the
prevalence of ‘diagnosed asthma’ from the lowest to
highest proportion. We found the prevalence in Ile-Ife
lower than rates reported for European countries and
other low and middle income countries like Algeria (Algiers)
and India (Mumbai).Discussion
We found a low prevalence of asthma symptoms in Ile-Ife,
Nigeria. We observed that 1$5% of Ife population aged 15
years and above, have either a previous attack of asthma orTable 2 Estimated population distribution of asthma symptoms
Age group 15e19 years
(n Z 289)
Question 95% CI
Q1 Wheeze 1.7 (0.3e3.3
Q1.1 Wheeze with breathlessness 1.0 (0.1e2
Q1.2 Wheeze with no cold 0.4 (0.3e0
Q2 Woken up with chest tightness 1$7 (0.0e3
Q3 Woken up by shortness of breath 2.1 (0.3e3.7
Q4 Woken up by an attack of cough 3.8 (1.0e6.1
Q5 Attack of Asthma 0.7 (0.3e1
Q6 Currently taking asthma medications 1.4 (0$0e2$
Q5 or Q6 Diagnosed Asthma 1.7 (0.3e3.1
Q7 Nasal allergies 9.0 (5.2e12
CI e Confidence Interval, ECRHS - European Community Respiratory Hwere currently taking asthma medications within the pre-
ceding 12 months. In addition, 0.9% (95% CI: 0.5e1.3), 2$4%
(95% CI: 1.8e3.0), 2.9% (95% CI: 2.0e3.9 and, 9.1% (95% CI:
7.6e10.6) reported ‘wheeze’, ‘woken up by shortness of
breath, ‘woken up by an attack of coughing’ and ‘nasal
allergies’ respectively within the same period. Also, 3.2%
(95% CI: 2.6e3.9) of the respondents had symptoms
consistent with the ECRHS criteria for ‘probable asthma’
and the prevalence was lower than rates reported from
ECRHS global sites [16].
The International Study of Asthma and Allergies in
Childhood (ISAAC) in Nigeria showed that the prevalence of
asthma among young adolescents in an urban city in
Nigeria is substantial and in fact, increasing [17]. However
there is sparse information on the time trends among
adults. There is clearly a need for community studies with
a longitudinal perspective on the pattern of asthma among
adults in Nigeria. The present study is a baseline cross
sectional survey of the prevalence of adult asthma in Ile-
Ife, Nigeria.according to the ECRHS screening questionnaire.
20e44 years
(n Z 1223)
45 years & above
(n Z 798)
All (N Z 2310)
) 0.7 (0.2e1.1) 1.0 (0.4e1.6) 0.9 (0.5e1.3)
.2) 0$5 (0.1e0.9) 0.9 (0.3e1.5) 0$7 (0.3e1.0)
.9) 0.4 (0.1e0.8) 0.3 (0.1e0.6) 0.4 (0.1e0.6)
.3) 1.6 (0.8e2.3) 1.0 (0.3e1.8) 1$4 (0.8e1.9)
) 2.5 (1.6e3.3) 2.5 (1.3e3.7) 2.4 (1.8e3.0)
) 2.4 (1.5e3.2) 3.4 (1.8e5.0) 2$9 (2.0e3.7)
.6) 1.0 (0.4e1.5) 1.6 (0.8e2.5) 1.2 (0.8e1.5)
7) 0.4 (0.0e0.8) 1.0 (0.2e1.8) 0.7 (0.4e1.1)
) 1.2 (0.6e1.9) 1.9 (0.9e2.8) 1.5 (1.0e2.0)
.7) 7.5 (5.5e9.4) 11.8 (9.1e14.4) 9.1 (7.6e10.6)
ealth Survey.
Table 3 Prevalence of asthma symptoms by gender in the
respondents (n Z 2310).
Question
number
Symptoms
within
the last
12 months
Men
(n Z 859)
Women
(n Z 1451)
P
value
95% CI 95% CI
Q1 Wheeze 1.5
(0.7e2.3)
0.6
(0.2e0.9)
0.019
Q1.1 Wheeze with
breathlessness
0.9
(0.3e1.5)
0$6
(0.2e0.9)
0.287
Q1.2 Wheeze with
no cold
0.6
(0.1e1.1)
0$2
(0.0e0.4)
0.138
Q2 Woken up with
chest tightness
1.6
(0.8e2.5)
1$2
(0.7e1.8)
0.440
Q3 Woken up by
shortness
of breath
2.2
(1.2e3.2)
2$6
(1.8e3.3)
0.608
Q4 Woken up by an
attack of cough
3.3
(1.8e4.7)
2$7
(1.8e3.5)
0.430
Q5 Attack of asthma 0.9
(0.3e1.5)
1$3
(0.8e1.8)
0.414
Q6 Currently taking
asthma
medications
1.1
(0.4e1.7)
0$6
(0.1e1.0)
0.177
Q5 or Q6 Diagnosed
asthma
1.6
(0.8e2.4)
1$5
(0.9e2.0)
0.729
Q7 Nasal allergies 8.9
(6.4e11.1)
9$3
(7.3e11.2)
0.705
CI e confidence interval.
The results represent all aged 15 years and above who provided
complete questionnaire data.
Table 4 Characteristics of respondents with an affirmative resp
asthma” or Q6 “asthma medications” on the ECRHS screening qu
Men % (95% CI)
Probable asthma 3.1 (2.0e4.3)
Age range
15e19 years 26.2 (8.4e44.1)
20e44 years 41.6 (23.5e59.7)
45 years & above 32.1 (15.2e49.0)
ECRHS screening questionnaire symptoms in the last 12 months (
Wheeze 11.0 (0.9e22.9)
Wheeze with breathlessness 3.6 (3.4e10.6)
Wheeze with no cold 7.4 (2.7e17.4)
Woken up with chest tightness 7.4 (2.7e17.4)
Woken up by shortness of breath 69.9 (52.0e87.8)
Woken up by an attack of cough 29.3 (10.3e48.3)
Attack of asthma 29.2 (12.7e45.6)
Currently taking asthma medications 33.3 (15.1e51.7)
Diagnosed asthma 51.8 (33.5e70.1)
Nasal allergies 33.0 (15.6e50.4)
CI e confidence interval. ECRHS e European Community Respiratory
‘Probable asthma’ was defined by affirmative response to either Q3 “
“currently taking asthma medications”.
The prevalence rates reported for ‘probable asthma’ represent the
‘probable asthma’ criteria.
The questionnaire items are questions answered in the affirmative in
a Chi square test.
Low prevalence of asthma in sub Saharan Africa: A suburban community survey 1585Asthma prevalence varies based on the definition used.
Asthma diagnosis is mainly clinical as there is no specific set
of criteria for its diagnosis. The ECRHS however suggests
that in a community survey, asthma may be ‘probable’
based on the presence of affirmative responses to any of
the following questions: “Have you been woken up by an
attack of breathlessness at any time in the last 12 months”,
“Have you had an attack of asthma in the last 12 months” or
“Are you currently taking any medicines (including inhalers,
aerosols or tablets) for asthma?” These criteria have been
shown to have a specificity of 95%, but a low positive pre-
dictive value when bronchial hyper-reactivity is used as a
gold standard [12]. It is noteworthy, however, that the
ECRHS criteria may be less sensitive in low-income coun-
tries where a substantial proportion of the inhabitants may
not have access to proper health care for diagnosis or
treatment of asthma [18]. So, we also report an alternate
criterion that is based on affirmative response to any of the
following four questions: ‘Have you had wheezing or whis-
tling in your chest at any time in the last 12 months?’, ‘Have
you been woken by an attack of shortness of breath at any
time in the last 12 months?’, ‘Have you had an attack of
asthma in the last 12 months?’ or ‘Are you currently taking
any medicines (including inhalers, aerosols or tablets) for
asthma?”. Using this slightly more relaxed criteria, we
found that overall, the proportion with asthma was 3.7%
(95% CI: 3.0e4.5); men: 4.3% (95% CI: 2.9e5.7), women:
3.4% (95% CI: 2.5e4.3).
Our finding is consistent with previous reports, which
suggest that asthma is less common in rural African com-
munities compared with towns and cities [19,20], and much
less common compared with prevalence reported for
‘western’ societies [16,21]. The low prevalence of asthmaonse to Q3 “woken up by shortness of breath”, Q5 “attack of
estionnaire (n Z 75).
Women % (95% CI) All % (95% CI) P valuea
3.3 (2.4e4.2) 3.2 (2.6e3.9)
4.8 (1.7e11.4) 12.6 (4.2e20.9) 0.020
57.1 (41.9e72.4) 51.5 (39.3e63.8)
38.0 (22.6e53.4) 35.9 (24.1e47.7)
%)
12.4 (4.1e20.6) 11.9 (5.1e18.6) 0.859
12.4 (4.1e20.6) 9.2 (3.1e15.3) 0.209
6.2 (0.4e12.9) 6.7 (1.2e12.1) 0.847
25.0 (12.1e38.0) 18.7 (9.2e28.1) 0.061
77.0 (65.7e88.3) 74.4 (63.9e84.9) 0.521
30.8 (20.0e41.7) 30.3 (19.1e40.1) 0.844
39.5 (27.8e51.2) 35.7 (26.8e44.7) 0.389
16.9 (5.2e28.6) 22.9 (12.5e33.2) 0.098
43.6 (30.7e56.5) 46.6 (35.6e57.6) 0.500
36.2 (23.7e48.6) 35.0 (25.1e44.9) 0.806
Health Survey.
woken up by shortness of breath”, Q5 “attack of asthma” or Q6
sex stratified proportion of respondents who met ECRHS-defined
those who had ‘probable asthma’.
Table 5 Asthma percent prevalence among respondents aged 20e44 years in some ECRHS phase 1 sites sorted according to
diagnosed asthma (cf: Ile-Ife, Nigeria).
Centre Q1 Q1.1 Q1.2 Q2 Q3 Q4 Q5 Q6 Q6 or Q7 Q7
Wheeze Wheeze with
breathlessness
Wheeze
with
no cold
Chest
tightness
Breathlessness
at night
Cough
at
night
Asthma
attack
Asthma
medication
Diagnosed
asthma
Nasal
allergies
Ile-Ife, Nigeria 0.7 0.5 0.4 1.6 2.5 2.4 1.0 0.4 1.2 7.5
Erfurt, Germany 13.3 5.0 7.2 8.9 4.3 19.3 1.3 1.6 2.1 13.4
Athens, Greece 16.0 9.4 9.8 11.7 5.7 17.8 2.4 2.2 2.9 18.4
Algiers, Algeria 4.2 3.3 2.8 6.4 4.4 6.0 2.4 2.5 3.0 9.5
Barcelona, Spain 19.2 5.6 10.7 7.2 4.6 28.2 2.1 2.2 3.1 13.1
Pavia, Italy 8.5 1.4 5.1 6.2 6.9 28.9 2.6 1.3 3.3 12.5
Mumbai, India 4.1 3.0 2.0 7.0 6.8 11.2 2.6 2.8 3.5 10.1
Verona, Italy 9.7 1.4 6.6 8.0 6.2 27.8 3.7 2.0 4.2 16.9
Basel, Switzerland 16.9 9.9 11.9 15.1 7.6 29.1 3.9 3.5 5.4 24.0
Bordeaux, France 15.7 9.2 9.9 16.6 4.3 26.0 4.6 3.8 5.5 30.2
Coimbra, Portugal 19.0 9.8 12.9 18.8 10.6 25.2 4.3 4.9 6.0 16.7
Umea, Sweden 19.8 11.2 12.1 10.4 4.4 26.7 3.3 6.2 6.8 21.1
Portland,
Oregon, USA.
25.7 10.5 14.9 16.6 7.7 32.5 5.8 4.8 7.1 39.4
Cambridge,
United Kingdom
25.2 13.9 17.7 17.4 8.4 27.4 5.7 6.8 8.4 29.2
Christchurch,
New Zealand
26.7 15.8 18.7 18.8 10.4 31.7 8.7 9.1 11.2 36.1
ECRHS e European Community Respiratory Health Survey.
Data of prevalence rates from ECRHS global sites was extracted from ‘Variations in the prevalence of respiratory symptoms, self-
reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS), ERJ
1996:9:687-95.
1586 D.O. Obaseki et al.found in Ife is unlikely to be due to social stigma, as asthma
is known locally to be different from tuberculosis and
reasonably well understood to be non-communicable. We
have no reason to suspect that it may be due to low
response or differences between non-responders and re-
sponders, though it was technically inoperative to obtain
basic data from active refusals or those unreached after
two contact attempts. In addition, our study population is a
low smoking population and the low prevalence of asthma
found in this community is consistent with low exposures
locally to cigarette smoke [22]. Low prevalence of asthma
has been reported in studies in many African communities
in Tanzania, Ethiopia, Ghana and South Africa
[20,21,23e25] with population prevalence generally about
3% but a few other studies have reported higher preva-
lence. Desalu and colleagues in a study in Ilorin, an urban
capital city in the middle belt of Nigeria [7], reported
prevalence of 15.2% among adult men and women aged
18e65 years. They used the ECRHS screening questionnaire
and applied a tripartite definition for asthma; affirmative
response to at least two asthma symptoms or physician
diagnosed asthma or peak flow variability of at least 10%.
In another report on the prevalence of asthma among
undergraduate university students at Obafemi Awolowo
University, Ile-Ife, aged 15e35 years, Erhabor and col-
leagues reported a prevalence rate of 14.1% based on
presence of three or more asthma symptoms or physician
diagnosis [6]. The present report, which is also based on
data from Ile-Ife, is interesting because it suggests a
notable disparity in the burden of asthma in the same city.We observed, contrastingly, much lower prevalence among
the local residents of Ile-Ife compared with previous re-
ports among young undergraduates in the university
campus. Various mechanisms have been postulated to
explain the disparity in asthma between communities in
Africa especially the ‘parasite load hypothesis’ [26,27].
Though we did not assess the IgE levels or stool parasite
load in our population, previous reports suggests that in
rural or less urbanized communities with high levels of
parasitic infestations, there are high IgE levels, potentially
saturating and blocking binding sites of asthma allergies,
resulting in low asthma symptoms [26,28]. Some reports
have gone further to infer that high parasitic infestation
probably confers a ‘protective’ status against the devel-
opment of asthma or its severe forms [26]. University
campus residents come from varied and generally higher
socio-economic backgrounds from within the country,
especially those able to gain admittance into a high profile
Nigerian university, as Obafemi Awolowo University. In the
absence of skin sensitivity test results or serum IgE assess-
ment which could have been indicative of atopic status, we
can only speculate about the possible role or interplay of
parasitic infestations among locals compared with univer-
sity students in explaining the disparity in self reported
asthma in Ile-Ife.
We also observed a disparity in the reported prevalence
of respiratory symptoms and nasal allergies. A similar trend
was noted in other African studies (Table 5). Allergic rhinitis
often precedes asthma and is known to be a risk factor for
the development of asthma, [29,30] but variations exist in
Low prevalence of asthma in sub Saharan Africa: A suburban community survey 1587baseline allergic sensitization, level of hygiene and innate
immunologic response across populations and warrants
further investigation [24]. Overall, the factors that deter-
mine asthma in African communities remain controversial
with conflicting reports about the role of atopy and para-
sitic infestations [31,32]. Atopy does not fully explain the
distribution of asthma in urban and rural African commu-
nities, neither does parasitic load clearly define the divide
between asthma in rural and urban communities in Nigeria
[25,33].
As in many previous reports on the influence of gender
on asthma prevalence and severity, we found that older
women tend to report more asthma symptoms than men
compared with younger age groups. This trend remains a
subject of interest in many studies on asthma epidemiology
and may be due to several factors including the relative
size of the airways as compared with lung size in men versus
women, variation in rates of lung growth and decline with
age, influence of hormonal changes on airway inflammation
and smooth muscle function, sex differences in industrial
and domestic exposures including dusts, irritants, aero-
allergens, and disparity in access to medical care and
proper asthma management [34e40].
Lastly, the prevalence of asthma in Ile-Ife is much lower
than prevalence reported in ECRHS global sites [16]. This is
not entirely surprising based on current knowledge about
asthma and its determinants especially the impact of
industrialization and lifestyle changes [8].
Our study has its strengths and weaknesses. These re-
sults are based on data from suburban Nigeria, where up-
wards of 70% of Nigerians live. We administered the
standardized but simplified ECRHS screening questionnaire
to a large representative sample of community dwellers in
Ile-Ife, Nigeria. We used translated versions of the ques-
tionnaire to enhance easy understanding of the questions
by the respondents, employed rigorous sampling methods
while taking account of the sampling weights and clustering
effect during the data analysis. Though the adjusted
response rate was 67.2%, the co-operation rate was 91%
(2310/2532) among those reached successfully.
We used interviewers for data collection rather than
self-administration because of the low level of literacy
among the respondents but after two contact attempts,
many potential respondents could not be reached, and
neither was it possible to obtain a minimal data on non-
participation. Also, this survey is based only on question-
naire data. Information on skin sensitivity to common al-
lergens and reversibility test to inhaled bronchodilators or
broncho-constrictors like methacholine, though not diag-
nostic, would have provided more details on the pattern of
the disease, its relation with atopy and other possible risk
factors. A reversibility test could also help in excluding
possible differentials like chronic obstructive pulmonary
disease especially in the older age group. Often times,
asthma may be subclinical and ‘silent’ in the absence of
broncho-provocative tests.
While variations exist in the distribution of adult asthma
and its risk factors, further point prevalence and time trend
studies in urban and industrialized cities in Nigeria are
needed in order to achieve a clearer understanding of the
distribution and determinants of asthma. This information
will support and guide health policy makers in makingpolicies that will ensure an equitable and strategic distri-
bution of healthcare resources.
In conclusion, our study showed that the prevalence of
asthma is low in suburban Nigeria.
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